Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort

Data-Driven Definitions for Active and Structural MRI Lesions in the Sacroiliac Joint in Spondyloarthritis and their Predictive Utility

(2021) Walter P Maksymowych et al.   RHEUMATOLOGY

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry

(2021) Xabier Michelena et al.   RHEUMATOLOGY

High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics

(2020) Thomas Renson et al.   ANNALS OF THE RHEUMATIC DISEASES

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort

(2020) Monika Hebeisen et al.   PLoS One

Spondyloarthritis: The Changing Landscape—Are We There Yet?

(2020) Xenofon Baraliakos et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Secukinumab improves signs and symptoms of non‐radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study

(2020) Atul Deodhar et al.   Arthritis & Rheumatology

Axial spondyloarthritis: concept, construct, classification and implications for therapy

(2020) Philip C. Robinson et al.   Nature Reviews Rheumatology

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts

(2019) Anne Boel et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

(2019) Michael M. Ward et al.   Arthritis & Rheumatology

Axial spondyloarthritis: time to stop the split 10 years on

(2019) Xabier Michelena et al.   Nature Reviews Rheumatology

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

(2019) Atul Deodhar et al.   LANCET

Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes

(2018) Ulrich Weber et al.   Arthritis & Rheumatology

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

(2018) Désirée van der Heijde et al.   LANCET

Axial spondyloarthritis

(2017) Joachim Sieper et al.   LANCET

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

(2016) Robert G W Lambert et al.   ANNALS OF THE RHEUMATIC DISEASES

Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

(2016) Bente Glintborg et al.   JOURNAL OF RHEUMATOLOGY

Ankylosing Spondylitis and Axial Spondyloarthritis

(2016) Joel D. Taurog et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials

(2015) X. Baraliakos et al.   JOURNAL OF RHEUMATOLOGY

Tumor Necrosis Factor-  Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome

(2015) J. Corli et al.   JOURNAL OF RHEUMATOLOGY

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

(2015) Dominique Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

(2015) J. Sieper et al.   Arthritis & Rheumatology

The changing clinical picture and epidemiology of spondyloarthritis

(2014) Astrid van Tubergen   Nature Reviews Rheumatology

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

(2014) Maxime Dougados et al.   Arthritis & Rheumatology

The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns

(2014) Atul Deodhar et al.   Arthritis & Rheumatology

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort

(2013) Adrian Ciurea et al.   ARTHRITIS AND RHEUMATISM

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

(2013) Sofia Ramiro et al.   ARTHRITIS RESEARCH & THERAPY

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Review: Nonradiographic axial spondyloarthritis: New definition of an old disease?

(2012) Joachim Sieper et al.   ARTHRITIS AND RHEUMATISM

Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study

(2011) Astrid van Tubergen et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

(2008) Hildrun Haibel et al.   ARTHRITIS AND RHEUMATISM